Age-Dependent Hepatic UDP-Glucuronosyltransferase Gene Expression and Activity in Children
- PMID: 27899892
- PMCID: PMC5110524
- DOI: 10.3389/fphar.2016.00437
Age-Dependent Hepatic UDP-Glucuronosyltransferase Gene Expression and Activity in Children
Abstract
UDP-glucuronosyltransferases (UGTs) are important phase II drug metabolism enzymes. The aim of this study was to explore the relationship between age and changes in mRNA expression and activity of major human hepatic UGTs, as well as to understand the potential regulatory mechanism underlying this relationship. Using previously generated data, we investigated age-dependent mRNA expression levels of 11 hepatic UGTs (UGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A9, UGT2B4, UGT2B7, UGT2B10, UGT2B15, and UGT2B17) and 16 transcription factors (AHR, AR, CAR, ESR2, FXR, GCCR, HNF1a, HNF3a, HNF3b, HNF4a, PPARA, PPARG, PPARGC, PXR, SP1, and STAT3) in liver tissue of donors (n = 38) ranging from 0 to 25 years of age. We also examined the correlation between age and microsomal activities using 14 known UGT drug substrates in the liver samples (n = 19) of children donors. We found a statistically significant increase (nominal p < 0.05) in the expression of UGT1A1, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT2B7, and UGT2B17, as well as glucuronidation activities of serotonin, testosterone, and vorinostat during the first 25 years of life. Expression of estrogen receptor 1 and pregnane X receptor, two strong UGT transcriptional regulators, were significantly correlated with both age and UGT mRNA expression (p ≤ 0.05). These results suggest that both UGT expression and activity increase during childhood and adolescence, possibly driven in part by hormonal signaling. Our findings may help explain inter-patient variability in response to medications among children.
Keywords: UDP-glucuronosyltransferase; age; children; liver; ontogeny.
Figures


Similar articles
-
Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes.J Clin Pharmacol. 2019 Sep;59 Suppl 1:S42-S55. doi: 10.1002/jcph.1493. J Clin Pharmacol. 2019. PMID: 31502688
-
Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver.Hum Mol Genet. 2014 Oct 15;23(20):5558-69. doi: 10.1093/hmg/ddu268. Epub 2014 May 30. Hum Mol Genet. 2014. PMID: 24879639 Free PMC article.
-
Developmental aspects of human hepatic drug glucuronidation in young children and adults.Gut. 2002 Feb;50(2):259-65. doi: 10.1136/gut.50.2.259. Gut. 2002. PMID: 11788570 Free PMC article.
-
Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.Methods Enzymol. 2005;400:104-16. doi: 10.1016/S0076-6879(05)00007-8. Methods Enzymol. 2005. PMID: 16399346 Review.
-
Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors.Biochem Pharmacol. 2012 Oct 15;84(8):1000-6. doi: 10.1016/j.bcp.2012.07.009. Epub 2012 Jul 20. Biochem Pharmacol. 2012. PMID: 22820246 Review.
Cited by
-
Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.Front Immunol. 2023 Aug 9;14:1100100. doi: 10.3389/fimmu.2023.1100100. eCollection 2023. Front Immunol. 2023. PMID: 37622118 Free PMC article.
-
The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.Clin Pharmacokinet. 2019 Feb;58(2):189-211. doi: 10.1007/s40262-018-0681-2. Clin Pharmacokinet. 2019. PMID: 29862468 Review.
-
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.Cancer Chemother Pharmacol. 2017 Nov;80(5):1013-1026. doi: 10.1007/s00280-017-3447-x. Epub 2017 Oct 7. Cancer Chemother Pharmacol. 2017. PMID: 28988277 Free PMC article.
-
Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population.Bioengineered. 2022 Mar;13(3):7709-7745. doi: 10.1080/21655979.2022.2036916. Bioengineered. 2022. PMID: 35290166 Free PMC article. Review.
-
Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.Eur J Clin Pharmacol. 2018 May;74(5):583-591. doi: 10.1007/s00228-018-2414-8. Epub 2018 Jan 16. Eur J Clin Pharmacol. 2018. PMID: 29340733
References
-
- Burchell B., Coughtrie M., Jackson M., Harding D., Fournel-Gigleux S., Leakey J., et al. (1989). Development of human liver UDP-glucuronosyltransferases. Dev. Pharmacol. Ther. 13 70–77. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous